BCL2 FAMILY INHIBITORS

被引：0
|
作者：
Dinardo, C. [1 ]
机构：
[1] Univ Texas MD Anderson, Dept Leukemia, Houston, TX USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS23
引用
收藏
页数：2
相关论文
共 50 条
  • [11] ARE THE BCL2 FAMILY INHIBITORS SUBSTRATES FOR THE MULTIDRUG RESISTANCE EFFLUX PUMP MDR1?
    Moghaddaskho, Farima
    Yao, Yuan
    Flensburg, Christoffer
    Gong, Jia-Nan
    White, Christine
    Majewski, Ian J.
    Roberts, Andrew
    Huang, David
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S78 - S79
  • [12] Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
    Berger, Stephanie
    Procko, Erik
    Margineantu, Daciana
    Lee, Erinna F.
    Shen, Betty W.
    Zelter, Alex
    Silva, Daniel-Adriano
    Chawla, Kusum
    Herold, Marco J.
    Gamier, Jean-Marc
    Johnson, Richard
    MacCoss, Michael J.
    Lessene, Guillaume
    Davis, Trisha N.
    Stayton, Patrick S.
    Stoddard, Barry L.
    Fairlie, W. Douglas
    Hockenbery, David M.
    Baker, David
    eLife, 2016, 5
  • [13] The inhibitors of apoptosis: there is more to life than Bcl2
    Peter Liston
    Wai Gin Fong
    Robert G Korneluk
    Oncogene, 2003, 22 : 8568 - 8580
  • [14] Bcl2 family proteins in carcinogenesis and the treatment of cancer
    Anna Frenzel
    Francesca Grespi
    Waldemar Chmelewskij
    Andreas Villunger
    Apoptosis, 2009, 14 : 584 - 596
  • [15] Bcl2 family proteins in carcinogenesis and the treatment of cancer
    Frenzel, Anna
    Grespi, Francesca
    Chmelewskij, Waldemar
    Villunger, Andreas
    APOPTOSIS, 2009, 14 (04) : 584 - 596
  • [16] Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors
    Voutsadakis, Ioannis A.
    GENE, 2022, 847
  • [17] BCL2 Inhibitors Target Diagnosed and Relapsed/Refractory AML
    Kontro, M.
    Majumder, M. M.
    Pemovska, T.
    Eldfors, S.
    Parsons, A.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Porkka, K.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 78 - 79
  • [18] Novel BCL2 inhibitors with anti-lymphoma activity
    Mensah, Afua Adjeiwaa
    Chatzigiannis, Christos M.
    Diamantis, Dimitrios A.
    Gkalpinos, Vasileios K.
    Arribas, Alberto
    Tzakos, Andreas G.
    Bertoni, Francesco
    CANCER RESEARCH, 2022, 82 (12)
  • [19] Induction of apoptosis and autophagy by small molecule BCL2 inhibitors
    Hickman, J.
    Geneste, O.
    Le Toumelin, G.
    Kroemer, G.
    Maiuri, C.
    Criollo, A.
    Rain, J. C.
    Gautier, F.
    Juin, P.
    BULLETIN DU CANCER, 2007, 94 (06) : 533 - 534
  • [20] Computational study on novel natural inhibitors targeting BCL2
    Lv, Xiaye
    Jiang, Yuting
    Wang, Xinhui
    Xie, HaoQun
    Dou, Gaojing
    Wang, Jing
    Yang, Wenzhuo
    Wang, Hongyu
    Li, Zijian
    Zhang, Xiangheng
    Chen, Zhenghe
    MEDICAL ONCOLOGY, 2021, 38 (08)
12345